MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.
Saved in:
| Title: | MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance. |
|---|---|
| Authors: | Wu, Xiaosheng1 (AUTHOR), Nowakowski, Kevin E.1 (AUTHOR), Abeykoon, Jithma P.1 (AUTHOR), Manske, Michelle1 (AUTHOR), Stenson, Mary J.1 (AUTHOR), Timm, Michael M.2 (AUTHOR), Hanson, Curtis A.2 (AUTHOR), Van Dyke, Daniel L.2 (AUTHOR), Dasari, Surendra3 (AUTHOR), Witzig, Thomas E.1 (AUTHOR) witzig.thomas@mayo.edu |
| Source: | European Journal of Haematology. Oct2021, Vol. 107 Issue 4, p458-465. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
